Summary
Elevance Health, Inc. (ELV) disclosed in an 8-K filing dated March 2, 2026, that it has been notified by the Centers for Medicare & Medicaid Services (CMS) of its intent to impose intermediate sanctions. These sanctions include suspending enrollment of new Medicare beneficiaries into the Company's Medicare Advantage-Prescription Drug (MA-PD) plans and halting certain communication activities to Medicare beneficiaries. The sanctions are slated to take effect on March 31, 2026, pending satisfactory resolution of the issues identified by CMS. The core of the CMS action relates to alleged noncompliance with Medicare Advantage risk adjustment data submission requirements for dates of service prior to April 3, 2023. Elevance Health has indicated that it revised its practices in April 2023 following updated regulatory guidance and is actively engaged with CMS to address these concerns. Importantly, the sanctions do not affect current MA-PD members' benefits or plans.
Key Highlights
- 1CMS intends to impose intermediate sanctions on Elevance Health's MA-PD plans, suspending new enrollment and certain communications.
- 2The sanctions are scheduled to begin on March 31, 2026, unless issues are resolved.
- 3The alleged noncompliance relates to risk adjustment data submissions for services prior to April 3, 2023.
- 4Elevance Health revised its practices in April 2023 and is cooperating with CMS.
- 5Current MA-PD members' benefits and plans are unaffected by these proposed sanctions.